Generic Oncology Drugs Market : Table of Content


  • Published On : Nov-2018 |
  • Pages : 176 Pages |
  • Format : Generic Oncology Drugs Market Generic Oncology Drugs Market Generic Oncology Drugs Market Generic Oncology Drugs Market

1. Executive Summary
     1.1. Market Overview
     1.2. Market Analysis
     1.3. FMI Analysis and Recommendations
     1.4. Wheel of Fortune

2. Market Introduction
     2.1. Market Taxonomy
     2.2. Market Definition

3. Generic Oncology Drugs Market Opportunity Analysis 
     3.1. Macro-Economic Factors
     3.2. Opportunity Analysis

4. Market Background

4.1. PESTLE Analysis
     4.2. Market Dynamics
            4.2.1. Drivers
            4.2.2. Restraints
            4.2.3. Trends
     4.3. Regulatory Scenario

5. Key Inclusions
     5.1. Generic Oncology Drugs Pipeline

6. North America Generic Oncology Drugs Market Analysis 2013–2017 and Forecast 2018–2028
     6.1. Introduction
     6.2. Historical Market Size (US$ Mn) Analysis By Country, 2013-2017
            6.2.1. U.S.
            6.2.2. Canada
     6.3. Market Size (US$ Mn) Forecast By Country, 2018-2028
     6.4. Historical Market Size (US$ Mn) Trend Analysis By Molecule Type, 2013-2017
            6.4.1. Large Molecule
            6.4.2. Small Molecule
     6.5. Market Size (US$ Mn) Forecast By Molecule Type, 2018-2028
     6.6. Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2013-2017
            6.6.1. Oral
            6.6.2. Parenteral
     6.7. Market Size (US$ Mn) Forecast By Route of Administration, 2018-2028
     6.8. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013-2017
            6.8.1. Hospital Pharmacy
            6.8.2. Retail Pharmacy
            6.8.3. Online Pharmacy
            6.8.4. Managed Care Institutions
     6.9. Market Size (US$ Mn) Forecast By Distribution Channel, 2018-2028
     6.10. Drivers and Restraints: Impact Analysis
     6.11. Market Attractiveness Analysis
            6.11.1. By Country
            6.11.2. By Molecule Type
            6.11.3. By Route of Administration
            6.11.4. By Distribution Channel

7. Western Europe Generic Oncology Drugs Market Analysis 2013–2017 and Forecast 2018–2028
     7.1. Introduction
     7.2. Historical Market Size (US$ Mn) Analysis By Country, 2013-2017
            7.2.1. Germany
            7.2.2. U.K
            7.2.3. France
            7.2.4. Italy
            7.2.5. Spain
            7.2.6. Rest of Western Europe
     7.3. Market Size (US$ Mn) Forecast By Country, 2018-2028
     7.1. Historical Market Size (US$ Mn) Trend Analysis By Molecule Type, 2013-2017
            7.1.1. Large Molecule
            7.1.2. Small Molecule
     7.2. Market Size (US$ Mn) Forecast By Molecule Type, 2018-2028
     7.3. Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2013-2017
            7.3.1. Oral
            7.3.2. Parenteral
     7.4. Market Size (US$ Mn) Forecast By Route of Administration, 2018-2028
     7.5. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013-2017
            7.5.1. Hospital Pharmacy
            7.5.2. Retail Pharmacy
            7.5.3. Online Pharmacy
            7.5.4. Managed Care Institutions
     7.6. Market Size (US$ Mn) Forecast By Distribution Channel, 2018-2028
     7.7. Drivers and Restraints: Impact Analysis
     7.8. Market Attractiveness Analysis
            7.8.1. By Country
            7.8.2. By Molecule Type
            7.8.3. By Route of Administration
            7.8.4. By Distribution Channel

8. Eastern Europe Generic Oncology Drugs Market Analysis 2013–2017 and Forecast 2018–2028
     8.1. Introduction
     8.2. Historical Market Size (US$ Mn) Analysis By Country, 2013-2017
            8.2.1. Russia
            8.2.2. Poland
            8.2.3. Rest of Eastern Europe
     8.3. Market Size (US$ Mn) Forecast By Country, 2018-2028
     8.1. Historical Market Size (US$ Mn) Trend Analysis By Molecule Type, 2013-2017
            8.1.1. Large Molecule
            8.1.2. Small Molecule
     8.2. Market Size (US$ Mn) Forecast By Molecule Type, 2018-2028
     8.3. Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2013-2017
            8.3.1. Oral
            8.3.2. Parenteral
     8.4. Market Size (US$ Mn) Forecast By Route of Administration, 2018-2028
     8.5. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013-2017
            8.5.1. Hospital Pharmacy
            8.5.2. Retail Pharmacy
            8.5.3. Online Pharmacy
            8.5.4. Managed Care Institutions
     8.6. Market Size (US$ Mn) Forecast By Distribution Channel, 2018-2028
     8.7. Drivers and Restraints: Impact Analysis
     8.8. Market Attractiveness Analysis
            8.8.1. By Country
            8.8.2. By Molecule Type
            8.8.3. By Route of Administration
            8.8.4. By Distribution Channel

9. Latin America Generic Oncology Drugs Market Analysis 2013–2017 and Forecast 2018–2028
     9.1. Introduction
     9.2. Historical Market Size (US$ Mn) Analysis By Country, 2013-2017
            9.2.1. Brazil
            9.2.2. Mexico
            9.2.3. Rest of Latin America
     9.3. Market Size (US$ Mn) Forecast By Country, 2018-2028
     9.1. Historical Market Size (US$ Mn) Trend Analysis By Molecule Type, 2013-2017
            9.1.1. Large Molecule
            9.1.2. Small Molecule
     9.2. Market Size (US$ Mn) Forecast By Molecule Type, 2018-2028
     9.3. Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2013-2017
            9.3.1. Oral
            9.3.2. Parenteral
     9.4. Market Size (US$ Mn) Forecast By Route of Administration, 2018-2028
     9.5. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013-2017
            9.5.1. Hospital Pharmacy
            9.5.2. Retail Pharmacy
            9.5.3. Online Pharmacy
            9.5.4. Managed Care Institutions
     9.6. Market Size (US$ Mn) Forecast By Distribution Channel, 2018-2028
     9.7. Drivers and Restraints: Impact Analysis
     9.8. Market Attractiveness Analysis
            9.8.1. By Country
            9.8.2. By Molecule Type
            9.8.3. By Route of Administration
            9.8.4. By Distribution Channel

10. Asia Pacific Excluding China & Japan Generic Oncology Drugs Market Analysis 2013–2017 and Forecast 2018–2028
     10.1. Introduction
     10.2. Historical Market Size (US$ Mn) Analysis By Country, 2013-2017
            10.2.1. India
            10.2.2. Australia and New Zealand
            10.2.3. ASEAN
            10.2.4. Rest of APECJ
     10.3. Market Size (US$ Mn) Forecast By Country, 2018-2028
     10.4.Historical Market Size (US$ Mn) Trend Analysis By Molecule Type, 2013-2017
            10.4.1. Large Molecule
            10.4.2. Small Molecule
     10.5. Market Size (US$ Mn) Forecast By Molecule Type, 2018-2028
     10.6.Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2013-2017
            10.6.1. Oral
            10.6.2. Parenteral
     10.7.Market Size (US$ Mn) Forecast By Route of Administration, 2018-2028
     10.8.Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013-2017
            10.8.1. Hospital Pharmacy
            10.8.2. Retail Pharmacy
            10.8.3. Online Pharmacy
            10.8.4. Managed Care Institutions
     10.9.Market Size (US$ Mn) Forecast By Distribution Channel, 2018-2028
     10.10. Drivers and Restraints: Impact Analysis
     10.11. Market Attractiveness Analysis
            10.11.1. By Country
            10.11.2. By Molecule Type
            10.11.3. By Route of Administration
            10.11.4. By Distribution Channel

11. China Generic Oncology Drugs Market Analysis 2013–2017 and Forecast 2018–2028
     11.1. Introduction
     11.1.Historical Market Size (US$ Mn) Trend Analysis By Molecule Type, 2013-2017
            11.1.1. Large Molecule
            11.1.2. Small Molecule
     11.2. Market Size (US$ Mn) Forecast By Molecule Type, 2018-2028
     11.3.Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2013-2017
            11.3.1. Oral
            11.3.2. Parenteral
     11.4.Market Size (US$ Mn) Forecast By Route of Administration, 2018-2028
     11.5.Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013-2017
            11.5.1. Hospital Pharmacy
            11.5.2. Retail Pharmacy
            11.5.3. Online Pharmacy
            11.5.4. Managed Care Institutions
     11.6.Market Size (US$ Mn) Forecast By Distribution Channel, 2018-2028
     11.7. Drivers and Restraints: Impact Analysis
     11.8. Market Attractiveness Analysis
            11.8.1. By Molecule Type
            11.8.2. By Route of Administration
            11.8.3. By Distribution Channel

12. Japan Generic Oncology Drugs Market Analysis 2013–2017 and Forecast 2018–2028
     12.1. Introduction
     12.1.Historical Market Size (US$ Mn) Trend Analysis By Molecule Type, 2013-2017
            12.1.1. Large Molecule
            12.1.2. Small Molecule
     12.2. Market Size (US$ Mn) Forecast By Molecule Type, 2018-2028
     12.3.Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2013-2017
            12.3.1. Oral
            12.3.2. Parenteral
     12.4.Market Size (US$ Mn) Forecast By Route of Administration, 2018-2028
     12.5.Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013-2017
            12.5.1. Hospital Pharmacy
            12.5.2. Retail Pharmacy
            12.5.3. Online Pharmacy
            12.5.4. Managed Care Institutions
     12.6.Market Size (US$ Mn) Forecast By Distribution Channel, 2018-2028
     12.7. Drivers and Restraints: Impact Analysis
     12.8. Market Attractiveness Analysis
            12.8.1. By Molecule Type
            12.8.2. By Route of Administration
            12.8.3. By Distribution Channel

13. Middle East and Africa Generic Oncology Drugs Market Analysis 2013–2017 and Forecast 2018–2028
     13.1. Introduction
     13.2. Historical Market Size (US$ Mn) Analysis By Country, 2013-2017
            13.2.1. GCC Countries
            13.2.2. South Africa
            13.2.3. Rest of Middle East and Africa
     13.3. Market Size (US$ Mn) Forecast By Country, 2018-2028
     13.1.Historical Market Size (US$ Mn) Trend Analysis By Molecule Type, 2013-2017
            13.1.1. Large Molecule
            13.1.2. Small Molecule
     13.2. Market Size (US$ Mn) Forecast By Molecule Type, 2018-2028
     13.3.Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2013-2017
            13.3.1. Oral
            13.3.2. Parenteral
     13.4.Market Size (US$ Mn) Forecast By Route of Administration, 2018-2028
     13.5.Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013-2017
            13.5.1. Hospital Pharmacy
            13.5.2. Retail Pharmacy
            13.5.3. Online Pharmacy
            13.5.4. Managed Care Institutions
     13.6.Market Size (US$ Mn) Forecast By Distribution Channel, 2018-2028
     13.7. Drivers and Restraints: Impact Analysis
     13.8. Market Attractiveness Analysis
            13.8.1. By Country
            13.8.2. By Molecule Type
            13.8.3. By Route of Administration
            13.8.4. By Distribution Channel

14. Forecast Factors: Relevance and Impact

15. Forecast Assumptions

16. Competition Analysis
     16.1.Competition Dashboard
     16.2.Company Deep Dive
            16.2.1. Novartis AG
                      16.2.1.1. Overview
                      16.2.1.2. Treatment and Application Portfolio
                      16.2.1.3. Product Footprint
                      16.2.1.4. Sales Footprint
                      16.2.1.5. Channel Footprint
                      16.2.1.6. Strategy
                                 16.2.1.6.1.1 Marketing Strategy
                                 16.2.1.6.1.2. Treatment Strategy
                                 16.2.1.6.1.3. Channel Strategy
            16.2.2. Pfizer Inc.
            16.2.3. GlaxoSmithKline plc
            16.2.4. CELGENE CORPORATION
            16.2.5. Teva Pharmaceutical Industries Ltd.
            16.2.6. Merck & Company, Inc
            16.2.7. Aurobindo Pharma.
            16.2.8. Hikma Pharmaceuticals PLC 
            16.2.9. Mylan N.V.
            16.2.10. NATCO Pharma Limited.

17. Global Generic Oncology Drugs Market Analysis 2013–2017 and Forecast 2018–2028 By Region
     17.1. Introduction / Key Findings
     17.2. Historical Market Size (US$ Mn) Analysis By Region
            17.2.1. North America
            17.2.2. Western Europe
            17.2.3. Eastern Europe
            17.2.4. Latin America
            17.2.5. Asia Pacific Excluding Japan
            17.2.6. Japan
            17.2.7. China
            17.2.8. Middle East and Africa
     17.3. Market Size (US$ Mn) Forecast By Region
     17.4. Market Attractiveness Analysis By Region

18. Global Generic Oncology Drugs Market Analysis 2013–2017 and Forecast 2018–2028, By Molecule Type
     18.1. Introduction/Key Finding
     18.2. Historical Market Size (US$ Mn) Trend Analysis By Molecule Type, 2013-2017
            18.2.1. Large Molecule
            18.2.2. Small Molecule
     18.3.Market Size (US$ Mn) Forecast By Molecule Type, 2018-2028
     18.4. Market Attractiveness Analysis By Molecule Type

19. Global Generic Oncology Drugs Market Analysis 2013–2017 and Forecast 2018–2028, By Route Of Administration
     19.1.Introduction/Key Finding
     19.2. Historical Market Size (US$ Mn) Trend Analysis By Route Of Administration, 2013-2017
            19.2.1. Oral
            19.2.2. Parenteral
     19.3.Market Size (US$ Mn) Forecast By Route Of Administration, 2018-2028
     19.4.Market Attractiveness Analysis By Route Of Administration

20. Global Generic Oncology Drugs Market Analysis 2013–2017 and Forecast 2018–2028, By Distribution Channel
     20.1.Introduction/Key Finding
     20.2. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013-2017
            20.2.1. Hospital Pharmacy
            20.2.2. Retail Pharmacy
            20.2.3. Online Pharmacy
            20.2.4. Managed Care Institutions
     20.3.Market Size (US$ Mn) Forecast By Distribution Channel, 2018-2028
     20.4.Market Attractiveness Analysis By Distribution Channel

21. Global Generic Oncology Drugs Market Analysis 2013–2017 and Forecast 2018–2028
     21.1.Market Value Share Analysis By All Segment
     21.2.Y-o-Y Growth Analysis By All Segment
     21.3.Absolute $ Opportunity

22. Assumptions and Acronyms Used

23. Research Methodology


List Of Table

Table 01: Generic Oncology Drugs Expected to be Launched by end of 2018
Table 02: North America Generic Oncology Drugs Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Country
Table 03: North America Generic Oncology Drugs Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Molecule Type
Table 04: North America Generic Oncology Drugs Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Route of Administration 
Table 05: North America Generic Oncology Drugs Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Distribution Channel
Table 06: Latin America Generic Oncology Drugs Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Country
Table 07: Latin America Generic Oncology Drugs Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Molecule Type
Table 08: Latin America Generic Oncology Drugs Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Route of Administration 
Table 09: Latin America Generic Oncology Drugs Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Distribution Channel
Table 10: Western Europe Generic Oncology Drugs Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Country
Table 11: Western Europe Generic Oncology Drugs Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Molecule Type
Table 12: Western Europe Generic Oncology Drugs Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Route of Administration 
Table 13: Western Europe Generic Oncology Drugs Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Distribution Channel
Table 14: Eastern Europe Generic Oncology Drugs Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Country
Table 15: Eastern Europe Generic Oncology Drugs Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Molecule Type
Table 16: Eastern Europe Generic Oncology Drugs Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Route of Administration 
Table 17: Eastern Europe Generic Oncology Drugs Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Distribution Channel
Table 18: APECJ Generic Oncology Drugs Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Country
Table 19: APECJ Generic Oncology Drugs Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Molecule Type
Table 20: APECJ Generic Oncology Drugs Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Route of Administration 
Table 21: APECJ Generic Oncology Drugs Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Distribution Channel
Table 22: China Generic Oncology Drugs Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Molecule Type
Table 23: China Generic Oncology Drugs Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Route of Administration 
Table 24: China Generic Oncology Drugs Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Distribution Channel
Table 25: China Generic Oncology Drugs Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Molecule Type
Table 26: China Generic Oncology Drugs Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Route of Administration 
Table 27: China Generic Oncology Drugs Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Distribution Channel
Table 28: MEA Generic Oncology Drugs Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Country
Table 29: MEA Generic Oncology Drugs Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Molecule Type
Table 30: MEA Generic Oncology Drugs Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Route of Administration 
Table 31: MEA Generic Oncology Drugs Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Distribution Channel
Table 32: Global Generic Oncology Drugs Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Region
Table 33: Global Generic Oncology Drugs Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Molecule Type
Table 34: Global Generic Oncology Drugs Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Route of Administration
Table 35: Global Generic Oncology Drugs Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Distribution Channel


List Of Figure

Figure 01: Generic Oncology Drugs Market Value Share By Region (2018)
Figure 02: Global Generic Oncology Drugs  Market Share, By Region (2017)
Figure 03: Global Generic Oncology Drugs  Market Share, By Molecule Type (2017)
Figure 04: Global Generic Oncology Drugs  Market Share, By Route of Administration Type (2017)
Figure 05: Global Generic Oncology Drugs  Market Share, By Distribution Channel (2017)
Figure 06: Distribution of Industry Sponsored Clinical Programs for Generic Oncology Drugs, by Phase
Figure 07: Number of Active Clinical Programs, by Major Indications
Figure 08: Geographical Distribution of Clinical Trials for Meningococcal Vaccines (2017)
Figure 09: North America Generic Oncology Drugs Market, Snapshot
Figure 10: North America Generic Oncology Drugs  Market Value Share, by Country (2017)
Figure 11: North America Generic Oncology Drugs  Market Value Share, by Molecule Type (2017)
Figure 12: North America Generic Oncology Drugs  Market Value Share, by Distribution Channel (2017)
Figure 13: North America Generic Oncology Drugs  Market Value Share, By Route of Administration (2017)
Figure 14: North America Generic Oncology Drugs Market Size (US$ Mn) Analysis, 2013–2017
Figure 15: North America Generic Oncology Drugs Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018–2028
Figure 16: North America Generic Oncology Drugs  Market Attractiveness Analysis, By Country
Figure 17: North America Generic Oncology Drugs  Market Attractiveness Analysis, By Molecule Type
Figure 18: North America Generic Oncology Drugs  Market Attractiveness Analysis, By Distribution Channel
Figure 19: North America Generic Oncology Drugs  Market Attractiveness Analysis, By Route of Administration
Figure 20: Latin America Generic Oncology Drugs Market, Snapshot
Figure 21: Latin America Generic Oncology Drugs  Market Value Share, by Country (2017)
Figure 22: Latin America Generic Oncology Drugs  Market Value Share, by Molecule Type (2017)
Figure 23: Latin America Generic Oncology Drugs  Market Value Share, by Distribution Channel (2017)
Figure 24: Latin America Generic Oncology Drugs  Market Value Share, By Route of Administration (2017)
Figure 25: Latin America Generic Oncology Drugs Market Size (US$ Mn) Analysis, 2013–2017
Figure 26: Latin America Generic Oncology Drugs Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018–2028
Figure 27: Latin America Generic Oncology Drugs  Market Attractiveness Analysis, By Country
Figure 28: Latin America Generic Oncology Drugs  Market Attractiveness Analysis, By Molecule Type
Figure 29: Latin America Generic Oncology Drugs  Market Attractiveness Analysis, By Distribution Channel
Figure 30: Latin America Generic Oncology Drugs  Market Attractiveness Analysis, By Route of Administration
Figure 31: Western Europe Generic Oncology Drugs Market, Snapshot
Figure 32: Western Europe Generic Oncology Drugs  Market Value Share, by Country (2017)
Figure 33: Western Europe Generic Oncology Drugs  Market Value Share, by Molecule Type (2017)
Figure 34: Western Europe Generic Oncology Drugs  Market Value Share, by Distribution Channel (2017)
Figure 35: Western Europe Generic Oncology Drugs  Market Value Share, By Route of Administration (2017)
Figure 36: Western Europe Generic Oncology Drugs Market Size (US$ Mn) Analysis, 2013–2017
Figure 37: Western Europe Generic Oncology Drugs Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018–2028
Figure 38: Western Europe Generic Oncology Drugs  Market Attractiveness Analysis, By Country
Figure 39: Western Europe Generic Oncology Drugs  Market Attractiveness Analysis, By Molecule Type
Figure 40: Western Europe Generic Oncology Drugs  Market Attractiveness Analysis, By Distribution Channel
Figure 41: Western Europe Generic Oncology Drugs  Market Attractiveness Analysis, By Route of Administration
Figure 42: Eastern Europe Generic Oncology Drugs Market, Snapshot
Figure 43: Eastern Europe Generic Oncology Drugs  Market Value Share, by Country (2017)
Figure 44: Eastern Europe Generic Oncology Drugs  Market Value Share, by Molecule Type (2017)
Figure 45: Eastern Europe Generic Oncology Drugs  Market Value Share, by Distribution Channel (2017)
Figure 46: Eastern Europe Generic Oncology Drugs  Market Value Share, By Route of Administration (2017)
Figure 47: Eastern Europe Generic Oncology Drugs Market Size (US$ Mn) Analysis, 2013–2017
Figure 48: Eastern Europe Generic Oncology Drugs Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018–2028
Figure 49: Eastern Europe Generic Oncology Drugs  Market Attractiveness Analysis, By Country
Figure 50: Eastern Europe Generic Oncology Drugs  Market Attractiveness Analysis, By Molecule Type
Figure 51: Eastern Europe Generic Oncology Drugs  Market Attractiveness Analysis, By Distribution Channel
Figure 52: Eastern Europe Generic Oncology Drugs  Market Attractiveness Analysis, By Route of Administration
Figure 53: APECJ Generic Oncology Drugs Market, Snapshot
Figure 54: APECJ Generic Oncology Drugs  Market Value Share, by Country (2017)
Figure 55: APECJ Generic Oncology Drugs  Market Value Share, by Molecule Type (2017)
Figure 56: APECJ Generic Oncology Drugs  Market Value Share, by Distribution Channel (2017)
Figure 57: APECJ Generic Oncology Drugs  Market Value Share, By Route of Administration (2017)
Figure 58: APECJ Generic Oncology Drugs Market Size (US$ Mn) Analysis, 2013–2017
Figure 59: APECJ Generic Oncology Drugs Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018–2028
Figure 60: APECJ Generic Oncology Drugs  Market Attractiveness Analysis, By Country
Figure 61: APECJ Generic Oncology Drugs  Market Attractiveness Analysis, By Molecule Type
Figure 62: APECJ Generic Oncology Drugs  Market Attractiveness Analysis, By Distribution Channel
Figure 63: APECJ Generic Oncology Drugs  Market Attractiveness Analysis, By Route of Administration
Figure 64: China Generic Oncology Drugs Market, Snapshot
Figure 65: China Generic Oncology Drugs  Market Value Share, by Molecule Type (2017)
Figure 66: China Generic Oncology Drugs  Market Value Share, by Route of Administration (2017)
Figure 67: China Generic Oncology Drugs  Market Value Share, By Distribution Channel (2017)
Figure 68: China Generic Oncology Drugs Market Size (US$ Mn) Analysis, 2013–2017
Figure 69: China Generic Oncology Drugs Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018–2028
Figure 70: China Generic Oncology Drugs  Market Attractiveness Analysis, By Molecule Type
Figure 71: China Generic Oncology Drugs  Market Attractiveness Analysis, By Route of Administration
Figure 72: China Generic Oncology Drugs  Market Attractiveness Analysis, By Distribution Channel
Figure 73: Japan Generic Oncology Drugs Market, Snapshot
Figure 74: Japan Generic Oncology Drugs  Market Value Share, By Molecule Type (2017)
Figure 75: Japan Generic Oncology Drugs  Market Value Share, By Route of Administration (2017)
Figure 76: Japan Generic Oncology Drugs  Market Value Share, By Distribution Channel (2017)
Figure 77: Japan Generic Oncology Drugs Market Size (US$ Mn) Analysis, 2013–2017
Figure 78: Japan Generic Oncology Drugs Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018–2028
Figure 79: China Generic Oncology Drugs  Market Attractiveness Analysis, By Molecule Type
Figure 80: China Generic Oncology Drugs  Market Attractiveness Analysis, By Route of Administration
Figure 81: China Generic Oncology Drugs  Market Attractiveness Analysis, By Distribution Channel
Figure 82: Middle East & Africa Generic Oncology Drugs Market, Snapshot
Figure 83: MEA Generic Oncology Drugs  Market Value Share, by Molecule Type (2017)
Figure 84: MEA Generic Oncology Drugs  Market Value Share, by Country (2017)
Figure 85: MEA Generic Oncology Drugs  Market Value Share, by Distribution Channel (2017)
Figure 86: MEA Generic Oncology Drugs  Market Value Share, By Route of Administration (2017)
Figure 87: Middle East & Africa Generic Oncology Drugs Market Size (US$ Mn) Analysis, 2013–2017
Figure 88: Middle East & Africa Generic Oncology Drugs Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018–2028
Figure 89: MEA Generic Oncology Drugs  Market Attractiveness Analysis, By Country
Figure 90: MEA Generic Oncology Drugs  Market Attractiveness Analysis, By Molecule Type
Figure 91: MEA Generic Oncology Drugs  Market Attractiveness Analysis, By Distribution Channel
Figure 92: MEA Generic Oncology Drugs  Market Attractiveness Analysis, By Route of Administration
Figure 93: Global Generic Oncology Drugs Market Attractiveness Analysis, By Region
Figure 94: Global Generic Oncology Drugs Market Value Share Analysis, By Region, 2017 & 2028
Figure 95: Global Generic Oncology Drugs Market Attractiveness Analysis, By Molecule Type 
Figure 96: Global Generic Oncology Drugs Market Value Share Analysis, By Molecule Type, 2017 & 2028
Figure 97: Global Generic Oncology Drugs Market Attractiveness Analysis, By Route of Administration 
Figure 98: Global Generic Oncology Drugs Market Value Share Analysis, By Route of Administration, 2017 & 2028
Figure 99: Global Generic Oncology Drugs Market Attractiveness Analysis, By Distribution Channel
Figure 100: Global Generic Oncology Drugs Market Value Share Analysis, By Distribution Channel, 2017 & 2028
Figure 101: Global Generic Oncology Drugs Market Size (US$ Mn) Analysis, 2013–2017
Figure 102: Global Generic Oncology Drugs Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018–2028
Figure 103: Global Generic Oncology Drugs Market Absolute $ Opportunity, 2013–2028

Generic Oncology Drugs Market - Table of Content

Back To Top